Market Tracker

11/21 6:05pm ET

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

2.95
Data as of Nov 21
 0.00 / 0.00%
Today’s Change
2.68
Today|||52-Week Range
5.25
-26.62%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close2.95
Today’s open3.00
Day’s range2.91 - 3.02
Volume61,074
Average volume (3 months)102,440
Market cap$67.8M
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+23.81%
Earnings growth (this year)+25.78%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,471.01%
P/E ratioNM
Price/Sales56.21
Price/Book2.04

Competitors

 Today’s
change
Today’s
% change
ASTMAastrom Biosciences ...-0.02-0.71%
LPCNLipocine Inc+0.30+5.89%
IPCIIntelliPharmaCeutics...+0.08+2.94%
GLMDGalmed Pharmaceutica...+0.39+7.10%
Data as of 4:00pm ET, 11/21/2014

Financials

Last reporting dateNovember 11, 2014
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$1.1M
Annual profit (last year)-$10.2M
Net profit margin-941.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts